ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Howard G. Welgus sold $257K of Arcutis Biotherapeutics, Inc.
Sold$256,518
$25.65Price
10,000Shares
−17%Stake
What ARQT did after the filing
- The stock from Thu, Mar 5 open, $23.70
- +3.5%
- S&P 500, same days
- +4.1%
Measured over 30 trading days, to the Apr 17 close.
Traded Mon, Mar 2. Filed Wed, Mar 4, 4:16 PM ET, after the close. Returns use the Mar 5 open and the Apr 17 close. Not investment advice.